Loading…
α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction
Oxidative stress has been implicated in neurodegenerative diseases, including glaucoma. However, due to the lack of clinically relevant models and expense of long-term testing, few studies have modeled antioxidant therapy for prevention of neurodegeneration. We investigated the contribution of oxida...
Saved in:
Published in: | PloS one 2013-06, Vol.8 (6), p.e65389 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c577t-b3f4a5fe08b5b942093511d7c98eb6f1b09bbc7c2753afb5f07600ee747241d23 |
---|---|
cites | cdi_FETCH-LOGICAL-c577t-b3f4a5fe08b5b942093511d7c98eb6f1b09bbc7c2753afb5f07600ee747241d23 |
container_end_page | |
container_issue | 6 |
container_start_page | e65389 |
container_title | PloS one |
container_volume | 8 |
creator | Inman, Denise M Lambert, Wendi S Calkins, David J Horner, Philip J |
description | Oxidative stress has been implicated in neurodegenerative diseases, including glaucoma. However, due to the lack of clinically relevant models and expense of long-term testing, few studies have modeled antioxidant therapy for prevention of neurodegeneration. We investigated the contribution of oxidative stress to the pathogenesis of glaucoma in the DBA/2J mouse model of glaucoma. Similar to other neurodegenerative diseases, we observed lipid peroxidation and upregulation of oxidative stress-related mRNA and protein in DBA/2J retina. To test the role of oxidative stress in disease progression, we chose to deliver the naturally occurring, antioxidant α-lipoic acid (ALA) to DBA/2J mice in their diet. We used two paradigms for ALA delivery: an intervention paradigm in which DBA/2J mice at 6 months of age received ALA in order to intervene in glaucoma development, and a prevention paradigm in which DBA/2J mice were raised on a diet supplemented with ALA, with the goal of preventing glaucoma development. At 10 and 12 months of age (after 4 and 11 months of dietary ALA respectively), we measured changes in genes and proteins related to oxidative stress, retinal ganglion cell (RGC) number, axon transport, and axon number and integrity. Both ALA treatment paradigms showed increased antioxidant gene and protein expression, increased protection of RGCs and improved retrograde transport compared to control. Measures of lipid peroxidation, protein nitrosylation, and DNA oxidation in retina verified decreased oxidative stress in the prevention and intervention paradigms. These data demonstrate the utility of dietary therapy for reducing oxidative stress and improving RGC survival in glaucoma. |
doi_str_mv | 10.1371/journal.pone.0065389 |
format | article |
fullrecord | <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_1365188076</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b3ce1f86f9374f8bbc4212eb11cc66fe</doaj_id><sourcerecordid>2988929031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c577t-b3f4a5fe08b5b942093511d7c98eb6f1b09bbc7c2753afb5f07600ee747241d23</originalsourceid><addsrcrecordid>eNp1ks1u1DAQxyMEoqXwBggicc7ij9hOLkioolBpJS7t2fLHOOuVEy92gtrH4kV4prpsWrUHTjPy_P-_GY2nqt5jtMFU4M_7uKRJhc0hTrBBiDPa9S-qU9xT0nCC6Msn-Un1Juc9QkXD-evqhFDBGCHstNr9_dNs_SF6Uyvjba2m2ccbb0us5wRqHqFkwY9-zvUQ1GLiqJoEQc1g6wSzLzPUg5qG4ONUGwihtsW2KyRb29vslskU5PS2euVUyPBujWfV9cW3q_Mfzfbn98vzr9vGMCHmRlPXKuYAdZrpviWopwxjK0zfgeYOa9RrbYQhglHlNHNIcIQARCtIiy2hZ9XHI_cQYpbrkrLElDPcdUVdFJdHhY1qLw_Jjyrdyqi8_PcQ0yBVmr0JIDU1gF3HXU9F67rSuSWYgMbYGM4dFNaXtduiR7CmLCup8Az6vDL5nRzib0m5oH2LCuDTCkjx1wJ5_s_I7VFlUsw5gXvsgJG8v4YHl7y_BrleQ7F9eDrdo-nh--kdT262kw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1365188076</pqid></control><display><type>article</type><title>α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction</title><source>Open Access: PubMed Central</source><source>ProQuest - Publicly Available Content Database</source><creator>Inman, Denise M ; Lambert, Wendi S ; Calkins, David J ; Horner, Philip J</creator><contributor>Ohlmann, Andreas</contributor><creatorcontrib>Inman, Denise M ; Lambert, Wendi S ; Calkins, David J ; Horner, Philip J ; Ohlmann, Andreas</creatorcontrib><description>Oxidative stress has been implicated in neurodegenerative diseases, including glaucoma. However, due to the lack of clinically relevant models and expense of long-term testing, few studies have modeled antioxidant therapy for prevention of neurodegeneration. We investigated the contribution of oxidative stress to the pathogenesis of glaucoma in the DBA/2J mouse model of glaucoma. Similar to other neurodegenerative diseases, we observed lipid peroxidation and upregulation of oxidative stress-related mRNA and protein in DBA/2J retina. To test the role of oxidative stress in disease progression, we chose to deliver the naturally occurring, antioxidant α-lipoic acid (ALA) to DBA/2J mice in their diet. We used two paradigms for ALA delivery: an intervention paradigm in which DBA/2J mice at 6 months of age received ALA in order to intervene in glaucoma development, and a prevention paradigm in which DBA/2J mice were raised on a diet supplemented with ALA, with the goal of preventing glaucoma development. At 10 and 12 months of age (after 4 and 11 months of dietary ALA respectively), we measured changes in genes and proteins related to oxidative stress, retinal ganglion cell (RGC) number, axon transport, and axon number and integrity. Both ALA treatment paradigms showed increased antioxidant gene and protein expression, increased protection of RGCs and improved retrograde transport compared to control. Measures of lipid peroxidation, protein nitrosylation, and DNA oxidation in retina verified decreased oxidative stress in the prevention and intervention paradigms. These data demonstrate the utility of dietary therapy for reducing oxidative stress and improving RGC survival in glaucoma.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0065389</identifier><identifier>PMID: 23755225</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acids ; Administration, Oral ; Age ; Animal models ; Animals ; Antioxidants ; Antioxidants - administration & dosage ; Axonal transport ; Axons - drug effects ; Axons - physiology ; Biology ; Cell death ; Cell Death - drug effects ; Deoxyribonucleic acid ; Diabetes ; Diabetic retinopathy ; Diet ; Dietary Supplements ; Disease ; DNA ; DNA Damage ; Drug Evaluation, Preclinical ; Free radicals ; Gene Expression ; Glaucoma ; Glaucoma - drug therapy ; Glaucoma - pathology ; Hypertension ; Intervention ; Intraocular Pressure - drug effects ; Lipid Peroxidation ; Lipids ; Lipoic acid ; Macular degeneration ; Medicine ; Metabolism ; Metabolites ; Mice ; Mice, Inbred C57BL ; Mice, Inbred DBA ; mRNA ; Nerve Degeneration - prevention & control ; Neurodegeneration ; Neurodegenerative diseases ; Neurological diseases ; Nitric oxide ; Nitric Oxide Synthase Type II - metabolism ; Nutrition therapy ; Oxidation ; Oxidation resistance ; Oxidation-Reduction ; Oxidative Stress ; Pathogenesis ; Peroxidation ; Prevention ; Proteins ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic - metabolism ; Retina ; Retina - drug effects ; Retina - metabolism ; Retina - pathology ; Retinal ganglion cells ; Retinal Ganglion Cells - drug effects ; Retinal Ganglion Cells - physiology ; Retrograde transport ; Rodents ; Therapy ; Thioctic Acid - administration & dosage ; Transport ; Treatment Outcome ; Up-Regulation</subject><ispartof>PloS one, 2013-06, Vol.8 (6), p.e65389</ispartof><rights>2013 Inman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2013 Inman et al 2013 Inman et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c577t-b3f4a5fe08b5b942093511d7c98eb6f1b09bbc7c2753afb5f07600ee747241d23</citedby><cites>FETCH-LOGICAL-c577t-b3f4a5fe08b5b942093511d7c98eb6f1b09bbc7c2753afb5f07600ee747241d23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1365188076/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1365188076?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23755225$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ohlmann, Andreas</contributor><creatorcontrib>Inman, Denise M</creatorcontrib><creatorcontrib>Lambert, Wendi S</creatorcontrib><creatorcontrib>Calkins, David J</creatorcontrib><creatorcontrib>Horner, Philip J</creatorcontrib><title>α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Oxidative stress has been implicated in neurodegenerative diseases, including glaucoma. However, due to the lack of clinically relevant models and expense of long-term testing, few studies have modeled antioxidant therapy for prevention of neurodegeneration. We investigated the contribution of oxidative stress to the pathogenesis of glaucoma in the DBA/2J mouse model of glaucoma. Similar to other neurodegenerative diseases, we observed lipid peroxidation and upregulation of oxidative stress-related mRNA and protein in DBA/2J retina. To test the role of oxidative stress in disease progression, we chose to deliver the naturally occurring, antioxidant α-lipoic acid (ALA) to DBA/2J mice in their diet. We used two paradigms for ALA delivery: an intervention paradigm in which DBA/2J mice at 6 months of age received ALA in order to intervene in glaucoma development, and a prevention paradigm in which DBA/2J mice were raised on a diet supplemented with ALA, with the goal of preventing glaucoma development. At 10 and 12 months of age (after 4 and 11 months of dietary ALA respectively), we measured changes in genes and proteins related to oxidative stress, retinal ganglion cell (RGC) number, axon transport, and axon number and integrity. Both ALA treatment paradigms showed increased antioxidant gene and protein expression, increased protection of RGCs and improved retrograde transport compared to control. Measures of lipid peroxidation, protein nitrosylation, and DNA oxidation in retina verified decreased oxidative stress in the prevention and intervention paradigms. These data demonstrate the utility of dietary therapy for reducing oxidative stress and improving RGC survival in glaucoma.</description><subject>Acids</subject><subject>Administration, Oral</subject><subject>Age</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Antioxidants - administration & dosage</subject><subject>Axonal transport</subject><subject>Axons - drug effects</subject><subject>Axons - physiology</subject><subject>Biology</subject><subject>Cell death</subject><subject>Cell Death - drug effects</subject><subject>Deoxyribonucleic acid</subject><subject>Diabetes</subject><subject>Diabetic retinopathy</subject><subject>Diet</subject><subject>Dietary Supplements</subject><subject>Disease</subject><subject>DNA</subject><subject>DNA Damage</subject><subject>Drug Evaluation, Preclinical</subject><subject>Free radicals</subject><subject>Gene Expression</subject><subject>Glaucoma</subject><subject>Glaucoma - drug therapy</subject><subject>Glaucoma - pathology</subject><subject>Hypertension</subject><subject>Intervention</subject><subject>Intraocular Pressure - drug effects</subject><subject>Lipid Peroxidation</subject><subject>Lipids</subject><subject>Lipoic acid</subject><subject>Macular degeneration</subject><subject>Medicine</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Inbred DBA</subject><subject>mRNA</subject><subject>Nerve Degeneration - prevention & control</subject><subject>Neurodegeneration</subject><subject>Neurodegenerative diseases</subject><subject>Neurological diseases</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Nutrition therapy</subject><subject>Oxidation</subject><subject>Oxidation resistance</subject><subject>Oxidation-Reduction</subject><subject>Oxidative Stress</subject><subject>Pathogenesis</subject><subject>Peroxidation</subject><subject>Prevention</subject><subject>Proteins</subject><subject>Receptor for Advanced Glycation End Products</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Retina</subject><subject>Retina - drug effects</subject><subject>Retina - metabolism</subject><subject>Retina - pathology</subject><subject>Retinal ganglion cells</subject><subject>Retinal Ganglion Cells - drug effects</subject><subject>Retinal Ganglion Cells - physiology</subject><subject>Retrograde transport</subject><subject>Rodents</subject><subject>Therapy</subject><subject>Thioctic Acid - administration & dosage</subject><subject>Transport</subject><subject>Treatment Outcome</subject><subject>Up-Regulation</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ks1u1DAQxyMEoqXwBggicc7ij9hOLkioolBpJS7t2fLHOOuVEy92gtrH4kV4prpsWrUHTjPy_P-_GY2nqt5jtMFU4M_7uKRJhc0hTrBBiDPa9S-qU9xT0nCC6Msn-Un1Juc9QkXD-evqhFDBGCHstNr9_dNs_SF6Uyvjba2m2ccbb0us5wRqHqFkwY9-zvUQ1GLiqJoEQc1g6wSzLzPUg5qG4ONUGwihtsW2KyRb29vslskU5PS2euVUyPBujWfV9cW3q_Mfzfbn98vzr9vGMCHmRlPXKuYAdZrpviWopwxjK0zfgeYOa9RrbYQhglHlNHNIcIQARCtIiy2hZ9XHI_cQYpbrkrLElDPcdUVdFJdHhY1qLw_Jjyrdyqi8_PcQ0yBVmr0JIDU1gF3HXU9F67rSuSWYgMbYGM4dFNaXtduiR7CmLCup8Az6vDL5nRzib0m5oH2LCuDTCkjx1wJ5_s_I7VFlUsw5gXvsgJG8v4YHl7y_BrleQ7F9eDrdo-nh--kdT262kw</recordid><startdate>20130605</startdate><enddate>20130605</enddate><creator>Inman, Denise M</creator><creator>Lambert, Wendi S</creator><creator>Calkins, David J</creator><creator>Horner, Philip J</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20130605</creationdate><title>α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction</title><author>Inman, Denise M ; Lambert, Wendi S ; Calkins, David J ; Horner, Philip J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c577t-b3f4a5fe08b5b942093511d7c98eb6f1b09bbc7c2753afb5f07600ee747241d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acids</topic><topic>Administration, Oral</topic><topic>Age</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Antioxidants - administration & dosage</topic><topic>Axonal transport</topic><topic>Axons - drug effects</topic><topic>Axons - physiology</topic><topic>Biology</topic><topic>Cell death</topic><topic>Cell Death - drug effects</topic><topic>Deoxyribonucleic acid</topic><topic>Diabetes</topic><topic>Diabetic retinopathy</topic><topic>Diet</topic><topic>Dietary Supplements</topic><topic>Disease</topic><topic>DNA</topic><topic>DNA Damage</topic><topic>Drug Evaluation, Preclinical</topic><topic>Free radicals</topic><topic>Gene Expression</topic><topic>Glaucoma</topic><topic>Glaucoma - drug therapy</topic><topic>Glaucoma - pathology</topic><topic>Hypertension</topic><topic>Intervention</topic><topic>Intraocular Pressure - drug effects</topic><topic>Lipid Peroxidation</topic><topic>Lipids</topic><topic>Lipoic acid</topic><topic>Macular degeneration</topic><topic>Medicine</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Inbred DBA</topic><topic>mRNA</topic><topic>Nerve Degeneration - prevention & control</topic><topic>Neurodegeneration</topic><topic>Neurodegenerative diseases</topic><topic>Neurological diseases</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Nutrition therapy</topic><topic>Oxidation</topic><topic>Oxidation resistance</topic><topic>Oxidation-Reduction</topic><topic>Oxidative Stress</topic><topic>Pathogenesis</topic><topic>Peroxidation</topic><topic>Prevention</topic><topic>Proteins</topic><topic>Receptor for Advanced Glycation End Products</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Retina</topic><topic>Retina - drug effects</topic><topic>Retina - metabolism</topic><topic>Retina - pathology</topic><topic>Retinal ganglion cells</topic><topic>Retinal Ganglion Cells - drug effects</topic><topic>Retinal Ganglion Cells - physiology</topic><topic>Retrograde transport</topic><topic>Rodents</topic><topic>Therapy</topic><topic>Thioctic Acid - administration & dosage</topic><topic>Transport</topic><topic>Treatment Outcome</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Inman, Denise M</creatorcontrib><creatorcontrib>Lambert, Wendi S</creatorcontrib><creatorcontrib>Calkins, David J</creatorcontrib><creatorcontrib>Horner, Philip J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Inman, Denise M</au><au>Lambert, Wendi S</au><au>Calkins, David J</au><au>Horner, Philip J</au><au>Ohlmann, Andreas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2013-06-05</date><risdate>2013</risdate><volume>8</volume><issue>6</issue><spage>e65389</spage><pages>e65389-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Oxidative stress has been implicated in neurodegenerative diseases, including glaucoma. However, due to the lack of clinically relevant models and expense of long-term testing, few studies have modeled antioxidant therapy for prevention of neurodegeneration. We investigated the contribution of oxidative stress to the pathogenesis of glaucoma in the DBA/2J mouse model of glaucoma. Similar to other neurodegenerative diseases, we observed lipid peroxidation and upregulation of oxidative stress-related mRNA and protein in DBA/2J retina. To test the role of oxidative stress in disease progression, we chose to deliver the naturally occurring, antioxidant α-lipoic acid (ALA) to DBA/2J mice in their diet. We used two paradigms for ALA delivery: an intervention paradigm in which DBA/2J mice at 6 months of age received ALA in order to intervene in glaucoma development, and a prevention paradigm in which DBA/2J mice were raised on a diet supplemented with ALA, with the goal of preventing glaucoma development. At 10 and 12 months of age (after 4 and 11 months of dietary ALA respectively), we measured changes in genes and proteins related to oxidative stress, retinal ganglion cell (RGC) number, axon transport, and axon number and integrity. Both ALA treatment paradigms showed increased antioxidant gene and protein expression, increased protection of RGCs and improved retrograde transport compared to control. Measures of lipid peroxidation, protein nitrosylation, and DNA oxidation in retina verified decreased oxidative stress in the prevention and intervention paradigms. These data demonstrate the utility of dietary therapy for reducing oxidative stress and improving RGC survival in glaucoma.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>23755225</pmid><doi>10.1371/journal.pone.0065389</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2013-06, Vol.8 (6), p.e65389 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1365188076 |
source | Open Access: PubMed Central; ProQuest - Publicly Available Content Database |
subjects | Acids Administration, Oral Age Animal models Animals Antioxidants Antioxidants - administration & dosage Axonal transport Axons - drug effects Axons - physiology Biology Cell death Cell Death - drug effects Deoxyribonucleic acid Diabetes Diabetic retinopathy Diet Dietary Supplements Disease DNA DNA Damage Drug Evaluation, Preclinical Free radicals Gene Expression Glaucoma Glaucoma - drug therapy Glaucoma - pathology Hypertension Intervention Intraocular Pressure - drug effects Lipid Peroxidation Lipids Lipoic acid Macular degeneration Medicine Metabolism Metabolites Mice Mice, Inbred C57BL Mice, Inbred DBA mRNA Nerve Degeneration - prevention & control Neurodegeneration Neurodegenerative diseases Neurological diseases Nitric oxide Nitric Oxide Synthase Type II - metabolism Nutrition therapy Oxidation Oxidation resistance Oxidation-Reduction Oxidative Stress Pathogenesis Peroxidation Prevention Proteins Receptor for Advanced Glycation End Products Receptors, Immunologic - metabolism Retina Retina - drug effects Retina - metabolism Retina - pathology Retinal ganglion cells Retinal Ganglion Cells - drug effects Retinal Ganglion Cells - physiology Retrograde transport Rodents Therapy Thioctic Acid - administration & dosage Transport Treatment Outcome Up-Regulation |
title | α-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A38%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B1-Lipoic%20acid%20antioxidant%20treatment%20limits%20glaucoma-related%20retinal%20ganglion%20cell%20death%20and%20dysfunction&rft.jtitle=PloS%20one&rft.au=Inman,%20Denise%20M&rft.date=2013-06-05&rft.volume=8&rft.issue=6&rft.spage=e65389&rft.pages=e65389-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0065389&rft_dat=%3Cproquest_plos_%3E2988929031%3C/proquest_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c577t-b3f4a5fe08b5b942093511d7c98eb6f1b09bbc7c2753afb5f07600ee747241d23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1365188076&rft_id=info:pmid/23755225&rfr_iscdi=true |